1. Update on Shingles

2. Epidemiology of Shingles in the United States

3. Some Common Misconceptions About Shingles

4. Shingles and Postherpetic Neuralgia (PHN)

5. Shingles and PHN Impact on Employment

6. Economic Burden of Adult Vaccine-Preventable Diseases in the United States

7. Why Are Adult Vaccination Rates So Low?

8. Adjuvant Enhances Shingles Vaccine

9. Bolster Patient Confidence in Vaccination

10. Adjuvants Are Safe

11. ACIP Shingrix Recommendations and Schedule

12. ACIP Shingrix Recommendations for Pregnant or Immunocompromised Patients

13. ZOE-50 Trial Shingrix Efficacy in Older Adults

14. ZOE-70 Trial Demonstrates Vaccine Efficacy

15. ZOE-70 Trial AEs and Reactogenicity

16. ZOE-50 Trial AEs and Reactogenicity

17. Zostavax

18. Differences Between Shingles Vaccines

19. Mixing and Administering Shingrix

20. Patient Education Is Key

21. If It's Longer Than 6 Months Don't Restart -- Pick Up

22. Interprofessional Teamwork

23. Make It Easy to Be Successful Second-Dose Reminders

24. Shingles Vaccination Resources

25. Be an Example

26. Abbreviations